查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1526895

2024 年生物防御全球市场报告

Biodefense Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

生物防御市场规模预计在未来几年将强劲成长。 2028年将以9.2%的年复合成长率（CAGR）成长至263.8亿美元。预计的成长因素包括新感染疾病的出现、生物技术的进一步进步、支持全球生物防御努力的更强有力的国际合作和资金筹措机制、生物防御基础设施的加强和现代化、公众意识和教育的提高、政策和法律规范。预测期内预计的主要趋势包括在预测建模、威胁检测和创建新的生物防御工具、远端医疗和远端监控中利用人工智慧和机器学习来早期检测和管理生物威胁，其中包括技术集成，重点是资料主导技术。

由于新兴感染疾病的持续威胁，生物防御市场预计将成长。这些疾病由细菌、病毒、寄生虫和真菌等多种微生物引起，凸显了生物防御领域病原体控制、快速反应策略、全球协调和准备的持续挑战。生物防御对于透过改善对生物威胁的准备、早期发现和快速反应来控制感染疾病和减少其对公共卫生的影响至关重要。例如，2023年11月，世界卫生组织（WHO）估计，2022年，全球将有约1,060万结核病患者，影响全球数百万人。这些反覆出现的威胁正在推动生物防御市场的成长。

生物防御领域的主要企业正在积极开发创新解决方案，例如 COVID-19经鼻吸入型疫苗，以加强世界对生物危害的准备。经鼻吸入型疫苗的优点包括给药方便、黏膜免疫潜力、减少对针头的依赖、增加可用性以及增强免疫反应的潜力。例如，Bharat Biotech International Limited于2023年1月推出了COVID-19经鼻吸入型疫苗iNCOVACC。该疫苗是使用携带预融合稳定刺突蛋白的重组复製缺陷型腺病毒载体开发的，并成功通过了 I、II 和 III 期试验。它以滴鼻剂的形式给药，分两次给药，间隔 4 週，每个鼻孔滴 4 滴。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球生物防御市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球生物防御市场表现：规模与成长，2018-2023
  • 全球生物防御市场预测：规模与成长，2023-2028 年、2033 年

第六章 市场细分

  • 全球生物防御市场：按类型、实际和预测划分，2018-2023、2023-2028、2033
  • 炭疽菌
  • 天花
  • 肉毒中毒
  • 辐射还是核？
  • 其他类型
  • 全球生物防御市场：生物威胁侦测设备的性能与预测，2018-2023、2023-2028、2033
  • 采样器
  • 检测器或触发装置
  • 识别符
  • 化验
  • 其他生物威胁侦测装置
  • 全球生物防御市场：按应用、性能和预测，2018-2023、2023-2028、2033
  • 医院和诊所
  • 门诊治疗中心
  • 其他用途

第 7 章 区域/国家分析

  • 全球生物防御市场：按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球生物防御市场：依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 生物防御市场：竞争格局
  • 生物防御市场：公司简介
    • Pfizer Inc.
    • Johnson & Johnson
    • Merck & Co.
    • Sanofi SA
    • Bristol-Myers Squibb Company

第三十一章 其他重大及创新企业

  • AstraZeneca Plc
  • GSK plc
  • Gilead Sciences Inc
  • Biogen Inc
  • Novavax Inc
  • Ichor Medical Systems
  • Emergent BioSolutions Inc.
  • Alnylam Pharmaceuticals Inc.
  • Dynavax Technologies
  • Bavarian Nordic
  • Siga Technologies Inc.
  • Elusys Therapeutics Inc.
  • Ology Bioservices
  • Altimmune Inc.
  • Hytest Limited

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r18544

Biodefense encompasses strategies and measures aimed at safeguarding against biological threats, including intentional releases of pathogens or biotoxins. These efforts involve developing detection systems, vaccines, treatments, and emergency response plans to minimize the impact of biological attacks on public health and safety. Additionally, biodefense includes research and policies to prevent the misuse of biological agents.

The primary types of biodefense include anthrax, smallpox, botulism, radiation or nuclear threats, and others. Anthrax is a severe infectious disease caused by Bacillus anthracis, affecting humans and animals. It can be contracted through skin contact, inhalation, or ingestion of spores. Various biothreat detection devices, such as samplers, detectors, identifiers, assays, and more, are utilized in settings such as hospitals, clinics, ambulatory care centers, and beyond.

The biodefense research report is one of a series of new reports from The Business Research Company that provides biodefense market statistics, including the biodefense industry's global market size, regional shares, competitors with a biodefense market share, detailed biodefense market segments, market trends and opportunities, and any further data you may need to thrive in the biodefense industry. This biodefense market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biodefense market size has grown strongly in recent years. It will grow from $17.01 billion in 2023 to $18.55 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The historic period's growth can be attributed to heightened government investment in biodefense programs and initiatives, bolstering regulatory frameworks to expedite biodefense product and technology approvals, improved collaboration among government agencies, private sector entities, and academic institutions, and mounting geopolitical tensions and apprehensions regarding bioterrorism.

The biodefense market size is expected to see strong growth in the next few years. It will grow to $26.38 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The forecasted growth can be attributed to several factors, the ongoing emergence of new infectious diseases, further advancements in biotechnology, strengthened international collaboration and funding mechanisms supporting global biodefense efforts, the enhancement and modernization of biodefense infrastructure, increased public awareness and education on biodefense matters, continual evolution of policies and regulatory frameworks to facilitate innovative biodefense technologies, and growing private sector investment in biodefense research and development. Major trends expected in the forecast period include the utilization of AI and machine learning for predictive modeling, threat detection, and the creation of new biodefense tools, integration of telehealth and remote monitoring technologies for early detection and management of biological threats, a focus on developing next-generation vaccines and therapeutics along with AI-driven drug discovery and development processes, and enhanced genomic surveillance and data analytics capabilities.

The biodefense market is anticipated to experience growth due to the persistent threat of emerging infectious diseases. These diseases, caused by various microorganisms such as bacteria, viruses, parasites, or fungi, highlight the ongoing challenges in pathogen control, rapid response strategies, global coordination, and readiness within the biodefense sector. Biodefense is crucial for managing infectious diseases by improving preparedness, early detection, and swift response to biological threats, thus mitigating their impact on public health. For example, in November 2023, the World Health Organization (WHO) estimated a global tuberculosis (TB) case count of around 10.6 million in 2022, affecting millions of individuals worldwide. This recurring threat underscores the driving force behind the growth of the biodefense market.

Leading companies in the biodefense sector are actively developing innovative solutions, such as nasal COVID-19 vaccines, to bolster global readiness against biological hazards. Nasal vaccines offer advantages such as easier administration, potential for mucosal immunity, reduced reliance on needles, increased accessibility, and potentially enhanced immune responses. For instance, Bharat Biotech International Limited launched the iNCOVACC Nasal COVID-19 vaccine in January 2023. This vaccine, developed using a recombinant replication-deficient adenovirus vector with a pre-fusion stabilized spike protein, underwent successful phase I, II, and III trials. Administered via nasal drops, it involves a 2-dose series given 4 weeks apart, with 4 drops into each nostril.

In September 2022, Emergent BioSolutions Inc. acquired worldwide rights to the TEMBEXA (brincidofovir) smallpox oral antiviral drug from Chimerix for $238 million. This acquisition underscores Emergent BioSolutions' commitment to advancing public health initiatives and addressing global health threats, particularly against smallpox outbreaks. Chimerix Inc., a biotechnology research company, is known for providing biodefense solutions.

Major companies operating in the biodefense market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals

North America was the largest region in the biodefense market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodefense market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biodefense market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biodefense market consists of revenues earned by entities by providing services such as threat assessment, surveillance, training, consultation, strategy development, emergency planning, and facility management. The market value includes the value of related goods sold by the service provider or included within the service offering. The biodefense market also includes sales of detection equipment, personal protective gear, vaccines and pharmaceuticals, biological agent identification kits, biocontainment equipment, emergency response kits, biosecurity systems, and communication systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biodefense Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biodefense market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biodefense ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biodefense market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Anthrax; Smallpox; Botulism; Radiation Or Nuclear; Other Types
  • 2) By Biothreat Detection Device: Samplers; Detectors Or Triggering Devices; Identifiers; Assays; Other Biothreat Detection Devices
  • 3) By Application: Hospitals And Clinics; Ambulatory Care Centers; Other Applications
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co.; Sanofi SA; Bristol-Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biodefense Market Characteristics

3. Biodefense Market Trends And Strategies

4. Biodefense Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Biodefense Market Size and Growth

  • 5.1. Global Biodefense Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Biodefense Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Biodefense Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biodefense Market Segmentation

  • 6.1. Global Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Anthrax
  • Smallpox
  • Botulism
  • Radiation Or Nuclear
  • Other Types
  • 6.2. Global Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Samplers
  • Detectors Or Triggering Devices
  • Identifiers
  • Assays
  • Other Biothreat Detection Devices
  • 6.3. Global Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Care Centers
  • Other Applications

7. Biodefense Market Regional And Country Analysis

  • 7.1. Global Biodefense Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Biodefense Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biodefense Market

  • 8.1. Asia-Pacific Biodefense Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biodefense Market

  • 9.1. China Biodefense Market Overview
  • 9.2. China Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biodefense Market

  • 10.1. India Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biodefense Market

  • 11.1. Japan Biodefense Market Overview
  • 11.2. Japan Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biodefense Market

  • 12.1. Australia Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biodefense Market

  • 13.1. Indonesia Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biodefense Market

  • 14.1. South Korea Biodefense Market Overview
  • 14.2. South Korea Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biodefense Market

  • 15.1. Western Europe Biodefense Market Overview
  • 15.2. Western Europe Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biodefense Market

  • 16.1. UK Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biodefense Market

  • 17.1. Germany Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biodefense Market

  • 18.1. France Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biodefense Market

  • 19.1. Italy Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biodefense Market

  • 20.1. Spain Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biodefense Market

  • 21.1. Eastern Europe Biodefense Market Overview
  • 21.2. Eastern Europe Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biodefense Market

  • 22.1. Russia Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biodefense Market

  • 23.1. North America Biodefense Market Overview
  • 23.2. North America Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biodefense Market

  • 24.1. USA Biodefense Market Overview
  • 24.2. USA Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biodefense Market

  • 25.1. Canada Biodefense Market Overview
  • 25.2. Canada Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biodefense Market

  • 26.1. South America Biodefense Market Overview
  • 26.2. South America Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biodefense Market

  • 27.1. Brazil Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biodefense Market

  • 28.1. Middle East Biodefense Market Overview
  • 28.2. Middle East Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biodefense Market

  • 29.1. Africa Biodefense Market Overview
  • 29.2. Africa Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biodefense Market Competitive Landscape And Company Profiles

  • 30.1. Biodefense Market Competitive Landscape
  • 30.2. Biodefense Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi SA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bristol-Myers Squibb Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Biodefense Market Other Major And Innovative Companies

  • 31.1. AstraZeneca Plc
  • 31.2. GSK plc
  • 31.3. Gilead Sciences Inc
  • 31.4. Biogen Inc
  • 31.5. Novavax Inc
  • 31.6. Ichor Medical Systems
  • 31.7. Emergent BioSolutions Inc.
  • 31.8. Alnylam Pharmaceuticals Inc.
  • 31.9. Dynavax Technologies
  • 31.10. Bavarian Nordic
  • 31.11. Siga Technologies Inc.
  • 31.12. Elusys Therapeutics Inc.
  • 31.13. Ology Bioservices
  • 31.14. Altimmune Inc.
  • 31.15. Hytest Limited

32. Global Biodefense Market Competitive Benchmarking

33. Global Biodefense Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Biodefense Market

35. Biodefense Market Future Outlook and Potential Analysis

  • 35.1 Biodefense Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Biodefense Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Biodefense Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer